Advertisement
Advertisement
Trending on Urology Times
1
Trial launches of molecular glue degrader plus apalutamide in mCRPC
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Datopotamab deruxtecan enters phase 3 trial in high-risk muscle-invasive urothelial cancer
4